Hyperfine (HYPR) Share-based Compensation (2021 - 2026)
Hyperfine (HYPR) reported Share-based Compensation of $647000.0 for Q1 2026, down 31.53% on a YoY basis from $945000.0 in Q1 2025, and down 6.5% quarter-over-quarter from $692000.0 in Q4 2025.
Hyperfine (HYPR) Share-based Compensation (2021 - 2026) Analysis & Trends
Hyperfine has reported Share-based Compensation for 6 years, with the latest figure at $647000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 31.53% year-over-year to $647000.0; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 41.45% YoY), and the FY2025 full-year result was $2.8 million, down 35.79% from the prior year.
- Share-based Compensation for Q1 2026 stood at $647000.0, down from $692000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $7.1 million in Q2 2022, with the low at -$2.4 million in Q3 2022.
- Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.1 million in 2024.
- The largest YoY upside for Share-based Compensation was 1439.7% in 2022 against a maximum downside of 271.2% in 2022.
- Hyperfine's Share-based Compensation stood at $1.8 million in 2022, then dropped by 28.17% to $1.3 million in 2023, then declined by 18.17% to $1.1 million in 2024, then plunged by 34.35% to $692000.0 in 2025, then decreased by 6.5% to $647000.0 in 2026.
- The last three Share-based Compensation figures came in at $647000.0 (Q1 2026), $692000.0 (Q4 2025), and $617000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | 647,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 647,000.00 |
| Mar 31, 2026 | 647,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 547,000.00 |
| Jun 30, 2025 | 547,000.00 |
| Mar 31, 2025 | 945,000.00 |
| Mar 31, 2025 | 945,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |